Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,206 | 469 | N/A | N/A | N/A |
| Receivables | 1,515 | 956 | N/A | N/A | N/A |
| Other current assets | 0 | 264 | 0 | 0 | 0 |
| TOTAL | $20,394 | $1,984 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 872 | 1,140 | N/A | N/A | N/A |
| Intangibles | 2,941 | 3,361 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,120 | 1,067 | 0 | 0 | 0 |
| TOTAL | $4,933 | $5,567 | $N/A | $N/A | $N/A |
| Total Assets | $25,327 | $7,552 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 867 | 3,710 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,281 | 1,083 | 0 | 0 | 0 |
| Accrued Expenses | 1,737 | 1,353 | N/A | N/A | N/A |
| Other current liabilities | 2,956 | 2,948 | N/A | N/A | N/A |
| TOTAL | $7,841 | $9,094 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 423 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 146 | 1,401 | 0 | 0 | 0 |
| TOTAL | $569 | $1,401 | $N/A | $N/A | $N/A |
| Total Liabilities | $8,410 | $10,495 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 2 | 1 | N/A | N/A | N/A |
| Retained earnings | -35,335 | -23,278 | N/A | N/A | N/A |
| TOTAL | $16,917 | $-2,943 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $25,327 | $7,552 | $0 | $0 | $0 |